Pricing database updated July 12, 2026Methodology v1.0How we score →
Compare Providers
Home / GLP-1 / GLP-1 eligibility: who qualifies and how clinicians decide
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Written by Dr. Parmis Mojarab, DO·Reviewed by Kim Callender, NP, FNP-BC·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

GLP-1 eligibility: who qualifies and how clinicians decide

Quick answer

GLP-1 eligibility is a clinical decision. For weight management, clinicians generally consider BMI thresholds (often ≥30, or ≥27 with a weight-related condition), medical history, contraindications and goals. No legitimate program prescribes without a licensed clinician's review.

Typical clinical criteria

Weight-management prescribing commonly follows BMI-based criteria — frequently a BMI of 30 or above, or 27 or above with a weight-related condition such as hypertension or type 2 diabetes — but the clinician weighs the whole picture, not a single number.

Contraindications

Personal or family history of medullary thyroid carcinoma or MEN 2, prior serious hypersensitivity, and pregnancy are key contraindications. History of pancreatitis or gallbladder disease requires careful review.

The eligibility process

A legitimate program collects medical history, current medications, allergies and pregnancy status, then has a licensed clinician review before any prescription. Questionnaire-only 'approval' without genuine clinical review is a red flag.

Frequently asked questions

Do I need a specific BMI for GLP-1 medication?

Weight-management prescribing often uses BMI thresholds, but eligibility is individual and determined by a clinician who reviews your full history.

Can I get GLP-1 medication without a prescription?

No. Any lawful pathway requires a licensed clinician's review and, if appropriate, a prescription.

Sources

  1. U.S. Food and Drug Administration — labels and safety communications.
  2. Peer-reviewed clinical trials cited above.
  3. Our methodology and medical review policy.

Spotted an error? Submit a correction.